Ventas, Inc. $VTR Shares Sold by Thrivent Financial for Lutherans

Thrivent Financial for Lutherans reduced its stake in shares of Ventas, Inc. (NYSE:VTR) by 6.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 108,146 shares of the real estate investment trust’s stock after selling 7,972 shares during the quarter. Thrivent Financial for Lutherans’ holdings in Ventas were worth $8,369,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its stake in shares of Ventas by 3.2% during the 4th quarter. Vanguard Group Inc. now owns 75,948,003 shares of the real estate investment trust’s stock worth $5,876,856,000 after purchasing an additional 2,349,176 shares in the last quarter. UBS Group AG increased its stake in shares of Ventas by 142.4% during the 3rd quarter. UBS Group AG now owns 3,507,841 shares of the real estate investment trust’s stock worth $245,514,000 after purchasing an additional 2,060,770 shares in the last quarter. Lasalle Investment Management Securities LLC increased its stake in shares of Ventas by 1,135.1% during the 3rd quarter. Lasalle Investment Management Securities LLC now owns 1,552,880 shares of the real estate investment trust’s stock worth $108,686,000 after purchasing an additional 1,427,151 shares in the last quarter. Invesco Ltd. boosted its position in Ventas by 21.5% during the third quarter. Invesco Ltd. now owns 5,847,604 shares of the real estate investment trust’s stock worth $409,274,000 after acquiring an additional 1,034,634 shares during the last quarter. Finally, State Street Corp boosted its position in Ventas by 3.3% during the third quarter. State Street Corp now owns 28,927,015 shares of the real estate investment trust’s stock worth $2,038,176,000 after acquiring an additional 928,386 shares during the last quarter. 94.18% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on VTR. Jefferies Financial Group raised their target price on shares of Ventas from $97.00 to $100.00 and gave the stock a “buy” rating in a research report on Tuesday, May 12th. Citigroup raised their target price on shares of Ventas from $96.00 to $100.00 and gave the stock a “buy” rating in a research report on Friday, May 1st. Weiss Ratings restated a “buy (b-)” rating on shares of Ventas in a research report on Friday, March 27th. Wells Fargo & Company raised their target price on shares of Ventas from $88.00 to $93.00 and gave the stock an “overweight” rating in a research report on Thursday, March 26th. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $93.00 target price on shares of Ventas in a research report on Monday, February 9th. Fourteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $94.63.

Insider Buying and Selling at Ventas

In other Ventas news, Director Walter C. Rakowich sold 1,152 shares of Ventas stock in a transaction on Thursday, May 14th. The shares were sold at an average price of $90.20, for a total value of $103,910.40. Following the transaction, the director owned 28,349 shares in the company, valued at $2,557,079.80. This trade represents a 3.90% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.53% of the stock is currently owned by company insiders.

Ventas Stock Up 0.3%

Shares of NYSE VTR opened at $88.38 on Wednesday. Ventas, Inc. has a 1 year low of $61.76 and a 1 year high of $91.06. The firm’s 50 day moving average price is $85.18 and its 200 day moving average price is $81.58. The firm has a market cap of $42.97 billion, a P/E ratio of 160.68, a price-to-earnings-growth ratio of 2.16 and a beta of 0.74. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.25 and a current ratio of 0.25.

Ventas (NYSE:VTR) last announced its quarterly earnings results on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). The company had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.59 billion. Ventas had a net margin of 4.25% and a return on equity of 2.09%. The firm’s revenue for the quarter was up 22.0% compared to the same quarter last year. During the same quarter last year, the business earned $0.84 EPS. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. As a group, sell-side analysts anticipate that Ventas, Inc. will post 3.86 earnings per share for the current year.

Ventas Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, July 16th. Shareholders of record on Tuesday, June 30th will be issued a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date is Tuesday, June 30th. Ventas’s dividend payout ratio (DPR) is 378.18%.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.